Download PDF
Hamostaseologie 2009; 29(S 01): S116
DOI: 10.1055/s-0037-1621505
Communication
Schattauer GmbH

Substrate specificity of vitamin K epoxide reductase C1

Substratspezifität der Vitamin-K-Epoxid-reduktase C1
M. Marinova
1   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
,
M. Watzka
1   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
,
P. Westhofen
1   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
,
M. Hass
1   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
,
D. Lütjohann
2   Institute of Clinical Biochemistry and Pharmacology, University Clinic Bonn, Germany
,
J. Oldenburg
1   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
04 January 2018 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Rost S, Fregin A, Ivaskevicius V. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427 6974 537-541.
    CrossrefPubMedGoogle Scholar
  • 2 Oldenburg J, Bevans CG, Müller CR, Watzka M. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxid Redox Signal 2006; 8: 347-353.
    CrossrefPubMedGoogle Scholar